Turner Christopher Durant
Nuvalent, Inc. · Chief Medical Officer
Turner Christopher Durant is listed in filings as Chief Medical Officer at Nuvalent, Inc.. This profile follows SEC Form 4 activity through Jan 7, 2026, including sale activity. Recent filings connect the profile to Nuvalent, Inc. (NUVL). The current snapshot covers public activity from Jan 7, 2026. Reported amounts are shown as $1.9M to $127.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $159k1.6k shares | SellJan 6, 2026 | $97.33 | $107.38 | |
| $128k1.3k shares | SellJan 6, 2026 | $96.75 | $107.38 | |
| $22k225 shares | SellJan 6, 2026 | $98.40 | $107.38 |